Valuation: Qiagen N.V.

Capitalization 10.2B 8.84B 8.27B 7.52B 13.86B 878B 15.73B 96.74B 37.68B 402B 38.26B 37.47B 1,470B P/E ratio 2025 *
24.6x
P/E ratio 2026 * 22.1x
Enterprise value 10.59B 9.17B 8.58B 7.8B 14.38B 911B 16.32B 100B 39.11B 417B 39.71B 38.89B 1,525B EV / Sales 2025 *
5.13x
EV / Sales 2026 * 4.62x
Free-Float
97.04%
Yield 2025 *
0.11%
Yield 2026 * 0.11%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.59%
1 week+3.58%
Current month+4.39%
1 month+11.87%
3 months+21.11%
6 months+0.88%
Current year+2.86%
More quotes
1 week 45.59
Extreme 45.59
47.4
1 month 41.11
Extreme 41.11
47.4
Current year 37.63
Extreme 37.63
49.3
1 year 37.63
Extreme 37.63
49.3
3 years 36.84
Extreme 36.8377
54.27
5 years 36.84
Extreme 36.8377
62.56
10 years 21.96
Extreme 21.9573
62.56
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 06/10/2019
Director of Finance/CFO 57 31/12/2003
Chief Operating Officer - 31/03/2022
Director TitleAgeSince
Director/Board Member 70 31/12/2003
Director/Board Member 76 31/05/2011
Chairman 67 20/08/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.59%+3.58%+5.65%+1.20% 10.2B
-2.50%-0.80%+18.23%+9.30% 49.5B
-1.41%+3.00%-26.67%-21.67% 27.14B
-1.89%+2.53%-3.84%+15.22% 26.06B
-0.17%+3.36%+13.43%-24.41% 12.53B
+0.07%+14.84% - - 12.34B
-0.97%+4.71%-54.18%-30.31% 11.57B
-2.49%-2.88%-81.64%-77.23% 10.31B
-0.07%-1.31%+33.60%+113.61% 10.31B
-1.89%+0.59%-24.32%+120.19% 8.57B
Average -1.19%+2.55%-13.30%+11.77% 17.85B
Weighted average by Cap. -1.53%+1.85%-6.18%+6.19%
See all sector performances

Financials

2025 *2026 *
Net sales 2.07B 1.79B 1.67B 1.52B 2.81B 178B 3.18B 19.59B 7.63B 81.41B 7.75B 7.59B 298B 2.19B 1.9B 1.78B 1.62B 2.98B 189B 3.38B 20.79B 8.1B 86.41B 8.22B 8.05B 316B
Net income 429M 371M 347M 316M 582M 36.89B 661M 4.06B 1.58B 16.89B 1.61B 1.57B 61.74B 470M 407M 380M 346M 638M 40.42B 724M 4.45B 1.73B 18.5B 1.76B 1.72B 67.65B
Net Debt 386M 335M 313M 285M 525M 33.24B 595M 3.66B 1.43B 15.22B 1.45B 1.42B 55.64B -80.65M -69.86M -65.35M -59.43M -110M -6.94B -124M -765M -298M -3.18B -302M -296M -11.62B
More financial data * Estimated data
Logo Qiagen N.V.
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Employees
5,700
Calendar
More about the company
Date Price Change Volume
13/06/25 47.11 $ -0.59% 1,064,958
12/06/25 47.39 $ +1.43% 1,102,841
11/06/25 46.72 $ +1.08% 1,443,360
10/06/25 46.22 $ +0.11% 1,806,933
09/06/25 46.17 $ +1.52% 1,842,962

Delayed Quote Nyse, June 13, 2025 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
47.11USD
Average target price
49.35USD
Spread / Average Target
+4.77%
Consensus

Quarterly revenue - Rate of surprise